Inventiva Pharma
Biopharmaceutical company specialising in nuclear receptors, transcription factors, and epigenetic modulation. Learn more
Launch date
Employees
Market cap
AUD187m
Enterprise valuation
AUD205m (Public information from Sep 2024)
Share price
$2.11 IVA
Company register number 537530255
Daix Bourgogne-Franche-Comté (HQ)
Authorizing premium user...